Combination immunotherapy shrinks a variety of metastatic gastrointestinal cancers in clinical trial

Combination immunotherapy shrinks a variety of metastatic gastrointestinal cancers in clinical trial

Source: Medical Xpress

A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment's effectiveness in patients with metastatic gastrointestinal cancers, according to results of a clinical trial led by researchers at the National Institutes of Health (NIH).

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Ten months after treatment with selected TIL therapy and pembrolizuma… [4185 chars]

Read more